Hermes Investment Management Ltd. boosted its holdings in West Pharmaceutical Services, Inc. (NYSE:WST) by 3.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 908,655 shares of the medical instruments supplier’s stock after buying an additional 28,955 shares during the period. West Pharmaceutical Services makes up about 1.3% of Hermes Investment Management Ltd.’s investment portfolio, making the stock its 11th largest position. Hermes Investment Management Ltd. owned about 1.23% of West Pharmaceutical Services worth $87,467,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also modified their holdings of WST. Acrospire Investment Management LLC bought a new stake in shares of West Pharmaceutical Services during the second quarter valued at approximately $113,000. Citigroup Inc. increased its position in shares of West Pharmaceutical Services by 95.1% during the second quarter. Citigroup Inc. now owns 1,569 shares of the medical instruments supplier’s stock valued at $148,000 after purchasing an additional 765 shares during the period. Wolverine Trading LLC bought a new stake in shares of West Pharmaceutical Services during the second quarter valued at approximately $200,000. Nomura Holdings Inc. bought a new stake in shares of West Pharmaceutical Services during the second quarter valued at approximately $201,000. Finally, Bradley Foster & Sargent Inc. CT bought a new stake in shares of West Pharmaceutical Services during the second quarter valued at approximately $212,000. 90.70% of the stock is currently owned by institutional investors.
West Pharmaceutical Services, Inc. (NYSE:WST) traded up 1.69% during mid-day trading on Friday, hitting $93.84. The stock had a trading volume of 327,015 shares. The stock’s 50 day moving average price is $93.42 and its 200 day moving average price is $91.55. West Pharmaceutical Services, Inc. has a one year low of $70.17 and a one year high of $99.91. The firm has a market capitalization of $6.94 billion, a price-to-earnings ratio of 40.27 and a beta of 1.12.
West Pharmaceutical Services (NYSE:WST) last posted its quarterly earnings data on Thursday, July 27th. The medical instruments supplier reported $0.66 EPS for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.01. West Pharmaceutical Services had a return on equity of 14.02% and a net margin of 11.42%. The firm had revenue of $397.60 million for the quarter, compared to analyst estimates of $406.00 million. During the same quarter last year, the company earned $0.59 EPS. The company’s revenue was up 2.5% on a year-over-year basis. Analysts forecast that West Pharmaceutical Services, Inc. will post $2.67 EPS for the current year.
A number of analysts have recently issued reports on WST shares. Jefferies Group LLC upgraded West Pharmaceutical Services from a “hold” rating to a “buy” rating and boosted their price objective for the company from $96.00 to $115.00 in a research report on Friday, September 15th. Stephens started coverage on West Pharmaceutical Services in a research report on Tuesday, October 3rd. They set an “equal weight” rating and a $99.00 price objective on the stock. Zacks Investment Research upgraded West Pharmaceutical Services from a “sell” rating to a “hold” rating in a research report on Wednesday, September 27th. BidaskClub cut West Pharmaceutical Services from a “buy” rating to a “hold” rating in a research report on Wednesday, July 5th. Finally, Bank of America Corporation cut West Pharmaceutical Services from a “buy” rating to a “neutral” rating and set a $98.00 price objective on the stock. in a research report on Tuesday. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $104.00.
TRADEMARK VIOLATION NOTICE: “West Pharmaceutical Services, Inc. (WST) Holdings Lifted by Hermes Investment Management Ltd.” was published by Transcript Daily and is the property of of Transcript Daily. If you are reading this piece on another domain, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The legal version of this piece can be read at https://transcriptdaily.com/2017/10/20/west-pharmaceutical-services-inc-wst-holdings-lifted-by-hermes-investment-management-ltd.html.
About West Pharmaceutical Services
West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.
Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with MarketBeat.com's FREE daily email newsletter.